Grant Number:	5R35CA253187-05 Interpret this number
Primary Investigator:	Couch, Fergus
Organization:	Mayo Clinic Rochester
Project Title:	Resolving the Cancer Relevance of Predisposition Gene Mutations
Fiscal Year:	2024

Breast cancer has a strong heritable component with approximately 15% of patients exhibiting a family history of the disease. My group recently established that inherited variants in 12 genes (ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, NF1, PALB2, PTEN, RAD51C, RAD51D, and TP53) predispose to breast cancer (1, 2), that variants in all 12 genes increase risks of breast cancer in minority populations (3), and that variants in certain genes predispose only to estrogen receptor (ER) positive (ATM and CHEK2) or ER negative and triple negative breast cancer (TNBC) (BARD1, RAD51C and RAD51D) (4-6). Despite these major advances, clinical application of the information is still lacking. In addition, up to 50% of the familial risk of breast cancer remains unexplained. Under this award we plan to address clinically relevant issues, including improved application of genetic testing results for risk management of patients and improved selection of breast cancer therapy. In addition, we aim to identify new breast cancer predisposition genes that account for the missing heritability. The proposed studies are unified under a theme of advancing understanding of predisposition genetics. The studies are as follows: A. Age-specific and population-specific cancer risk assessment for predisposition gene variants. Results from hereditary multigene panel testing has limited clinical utility because only lifetime risk estimates of cancer by age 80 are available. Here we will estimate 5 and 10-year risks of breast cancer, so that patients can make decisions about medical management. In addition, we have evidence that specific genes have much higher penetrance in African Americans. We will determine the penetrance of predisposition gene variants using a large African American cohort study in order to modify risk management guidelines for this population. B. Functional characterization of predisposition gene variants. Variants of uncertain significance (VUS) identified by genetic testing remain a major problem for individuals receiving clinical genetic testing. We aim to combine high-throughput functional analysis of VUS in ATM, BRCA2 and PALB2 genes with genetic data from families in integrated models to determine the clinical relevance of many VUS alterations. C. Therapeutic response for breast cancer predisposition genes. The responsiveness of breast tumors associated with predisposition gene variants to standard or targeted therapy is only known for BRCA1 and BRCA2 mutation carriers. Here we aim to identify all patients with pathogenic variants in the commonly mutated BRCA1, BRCA2, PALB2, ATM and CHEK2 genes from a series of neo-adjuvant, adjuvant and metastatic breast cancer clinical trials and to assess response to therapy and outcome. D. Identification of novel breast cancer predisposition alleles. The common and rare risk alleles for breast cancer account for only 50% of the familial risk in the population. In an effort to identify the missing heritability we will collaborate with Regeneron Inc. through our SIMPLEXO consortium to identify common and rare alleles associated with breast cancer risk in 45,000 breast cancer patients.




Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast.
Authors: Huang H. , Couch R.E. , Karam R. , Hu C. , Boddicker N. , Polley E.C. , Na J. , Ambrosone C.B. , Yao S. , Trentham-Dietz A. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2025-01-06 00:00:00.0; 31(1), p. 130-138.
PMID: 39513960
Related Citations

Germline copy number variants and endometrial cancer risk.
Authors: Stylianou C.E. , Wiggins G.A.R. , Lau V.L. , Dennis J. , Shelling A.N. , Wilson M. , Sykes P. , Amant F. , Annibali D. , De Wispelaere W. , et al. .
Source: Human Genetics, 2024 Dec; 143(12), p. 1481-1498.
EPub date: 2024-11-04 00:00:00.0.
PMID: 39495297
Related Citations

Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing.
Authors: Pal T. , Mundt E. , Richardson M.E. , Chao E. , Pesaran T. , Slavin T.P. , Couch F.J. , Monteiro A.N.A. .
Source: Npj Precision Oncology, 2024-11-02 00:00:00.0; 8(1), p. 247.
EPub date: 2024-11-02 00:00:00.0.
PMID: 39488595
Related Citations

Development of a breast cancer risk prediction model integrating monogenic, polygenic, and epidemiologic risk.
Authors: Kalia S.S. , Boddicker N.J. , Yadav S. , Huang H. , Na J. , Hu C. , Ambrosone C.B. , Yao S. , Haiman C.A. , Chen F. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2024-09-11 00:00:00.0; , .
EPub date: 2024-09-11 00:00:00.0.
PMID: 39259185
Related Citations

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel.
Authors: Parsons M.T. , de la Hoya M. , Richardson M.E. , Tudini E. , Anderson M. , Berkofsky-Fessler W. , Caputo S.M. , Chan R.C. , Cline M.S. , Feng B.J. , et al. .
Source: American Journal Of Human Genetics, 2024-09-05 00:00:00.0; 111(9), p. 2044-2058.
EPub date: 2024-08-13 00:00:00.0.
PMID: 39142283
Related Citations

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.
Authors: Zanti M. , O'Mahony D.G. , Parsons M.T. , Dorling L. , Dennis J. , Boddicker N.J. , Chen W. , Hu C. , Naven M. , Yiangou K. , et al. .
Source: Medrxiv : The Preprint Server For Health Sciences, 2024-09-04 00:00:00.0; , .
EPub date: 2024-09-04 00:00:00.0.
PMID: 39281752
Related Citations

Association of early menarche with breast tumor molecular features and recurrence.
Authors: Harris A.R. , Wang T. , Heng Y.J. , Baker G.M. , Le P.A. , Wang J. , Ambrosone C. , Brufsky A. , Couch F.J. , Modugno F. , et al. .
Source: Breast Cancer Research : Bcr, 2024-06-17 00:00:00.0; 26(1), p. 102.
EPub date: 2024-06-17 00:00:00.0.
PMID: 38886818
Related Citations

Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants.
Authors: Richardson M.E. , Holdren M. , Brannan T. , de la Hoya M. , Spurdle A.B. , Tavtigian S.V. , Young C.C. , Zec L. , Hiraki S. , Anderson M.J. , et al. .
Source: Medrxiv : The Preprint Server For Health Sciences, 2024-05-29 00:00:00.0; , .
EPub date: 2024-05-29 00:00:00.0.
PMID: 38854136
Related Citations

Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain.
Authors: Hu C. , Huang H. , Na J. , Lumby C. , Abozaid M. , Holdren M.A. , Rao T.J. , Karam R. , Pesaran T. , Weyandt J.D. , et al. .
Source: American Journal Of Human Genetics, 2024-03-07 00:00:00.0; 111(3), p. 584-593.
EPub date: 2024-02-27 00:00:00.0.
PMID: 38417439
Related Citations

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
Authors: Barnes D.R. , Tyrer J.P. , Dennis J. , Leslie G. , Bolla M.K. , Lush M. , Aeilts A.M. , Aittomäki K. , Andrieu N. , Andrulis I.L. , et al. .
Source: Medrxiv : The Preprint Server For Health Sciences, 2024-03-04 00:00:00.0; , .
EPub date: 2024-03-04 00:00:00.0.
PMID: 38496424
Related Citations

Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry.
Authors: Hughley R.W. , Matejcic M. , Song Z. , Sheng X. , Wan P. , Xia L. , Hart S.N. , Hu C. , Yadav S. , Lubwama A. , et al. .
Source: Cancer Research Communications, 2023-11-28 00:00:00.0; 3(12), p. 2544-50.
EPub date: 2023-11-28 00:00:00.0.
PMID: 38014910
Related Citations

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.
Authors: Levi H. , Carmi S. , Rosset S. , Yerushalmi R. , Zick A. , Yablonski-Peretz T. , BCAC Consortium , Wang Q. , Bolla M.K. , Dennis J. , et al. .
Source: Journal Of Medical Genetics, 2023-11-27 00:00:00.0; 60(12), p. 1186-1197.
EPub date: 2023-11-27 00:00:00.0.
PMID: 37451831
Related Citations

BRCA1 frameshift variants leading to extended incorrect protein C-termini.
Authors: Nepomuceno T.C. , Foo T.K. , Richardson M.E. , Ranola J.M.O. , Weyandt J. , Varga M.J. , Alarcon A. , Gutierrez D. , von Wachenfeldt A. , Eriksson D. , et al. .
Source: Hgg Advances, 2023-09-16 00:00:00.0; 4(4), p. 100240.
EPub date: 2023-09-16 00:00:00.0.
PMID: 37718511
Related Citations

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.
Authors: Stolarova L. , Kleiblova P. , Zemankova P. , Stastna B. , Janatova M. , Soukupova J. , Achatz M.I. , Ambrosone C. , Apostolou P. , Arun B.K. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2023-08-15 00:00:00.0; 29(16), p. 3037-3050.
PMID: 37449874
Related Citations

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.
Authors: Middha P. , Wang X. , Behrens S. , Bolla M.K. , Wang Q. , Dennis J. , Michailidou K. , Ahearn T.U. , Andrulis I.L. , Anton-Culver H. , et al. .
Source: Breast Cancer Research : Bcr, 2023-08-09 00:00:00.0; 25(1), p. 93.
EPub date: 2023-08-09 00:00:00.0.
PMID: 37559094
Related Citations

Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C.
Authors: Hu C. , Nagaraj A.B. , Shimelis H. , Montalban G. , Lee K.Y. , Huang H. , Lumby C.A. , Na J. , Susswein L.R. , Roberts M.E. , et al. .
Source: Cancer Research, 2023-08-01 00:00:00.0; 83(15), p. 2557-2571.
PMID: 37253112
Related Citations

Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts.
Authors: Kotsopoulos J. , Hathaway C.A. , Narod S.A. , Teras L.R. , Patel A.V. , Hu C. , Yadav S. , Couch F.J. , Tworoger S.S. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2023-07-26 00:00:00.0; , .
EPub date: 2023-07-26 00:00:00.0.
PMID: 37493628
Related Citations

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Authors: Morra A. , Schreurs M.A.C. , Andrulis I.L. , Anton-Culver H. , Augustinsson A. , Beckmann M.W. , Behrens S. , Bojesen S.E. , Bolla M.K. , Brauch H. , et al. .
Source: Cancer Medicine, 2023-07-03 00:00:00.0; , .
EPub date: 2023-07-03 00:00:00.0.
PMID: 37401034
Related Citations

Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival.
Authors: Lopes Cardozo J.M.N. , Andrulis I.L. , Bojesen S.E. , Dörk T. , Eccles D.M. , Fasching P.A. , Hooning M.J. , Keeman R. , Nevanlinna H. , Rutgers E.J.T. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2023-04-01 00:00:00.0; 41(10), p. 1849-1863.
EPub date: 2023-01-23 00:00:00.0.
PMID: 36689693
Related Citations

Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2.
Authors: Yadav S. , Boddicker N.J. , Na J. , Polley E.C. , Hu C. , Hart S.N. , Gnanaolivu R.D. , Larson N. , Holtegaard S. , Huang H. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2023-03-20 00:00:00.0; 41(9), p. 1703-1713.
EPub date: 2023-01-09 00:00:00.0.
PMID: 36623243
Related Citations

MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming.
Authors: Mohammed Ismail W. , Mazzone A. , Ghiraldini F.G. , Kaur J. , Bains M. , Munankarmy A. , Bagwell M.S. , Safgren S.L. , Moore-Weiss J. , Buciuc M. , et al. .
Source: Communications Biology, 2023-02-23 00:00:00.0; 6(1), p. 215.
EPub date: 2023-02-23 00:00:00.0.
PMID: 36823213
Related Citations

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Authors: Morra A. , Schreurs M.A.C. , Andrulis I.L. , Anton-Culver H. , Augustinsson A. , Beckmann M.W. , Behrens S. , Bojesen S.E. , Bolla M.K. , Brauch H. , et al. .
Source: Research Square, 2023-02-13 00:00:00.0; , .
EPub date: 2023-02-13 00:00:00.0.
PMID: 36824750
Related Citations

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.
Authors: Mueller S.H. , Lai A.G. , Valkovskaya M. , Michailidou K. , Bolla M.K. , Wang Q. , Dennis J. , Lush M. , Abu-Ful Z. , Ahearn T.U. , et al. .
Source: Genome Medicine, 2023-01-26 00:00:00.0; 15(1), p. 7.
EPub date: 2023-01-26 00:00:00.0.
PMID: 36703164
Related Citations

A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to BRCA1 and BRCA2.
Authors: Zanti M. , O'Mahony D.G. , Parsons M.T. , Li H. , Dennis J. , Aittomäkkiki K. , Andrulis I.L. , Anton-Culver H. , Aronson K.J. , Augustinsson A. , et al. .
Source: Human Mutation, 2023; 2023, .
EPub date: 2023-09-14 00:00:00.0.
PMID: 38725546
Related Citations

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Authors: Li H. , Engel C. , Hoya M. , Peterlongo P. , Yannoukakos D. , Livraghi L. , Radice P. , Thomassen M. , Hansen T.V.O. , Gerdes A.M. , et al. .
Source: Genetics In Medicine : Official Journal Of The American College Of Medical Genetics, 2022 Oct; 24(10), p. 2208.
PMID: 36205748
Related Citations

Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.
Authors: Dixon-Suen S.C. , Lewis S.J. , Martin R.M. , English D.R. , Boyle T. , Giles G.G. , Michailidou K. , Bolla M.K. , Wang Q. , Dennis J. , et al. .
Source: British Journal Of Sports Medicine, 2022 Oct; 56(20), p. 1157-1170.
EPub date: 2022-09-06 00:00:00.0.
PMID: 36328784
Related Citations

Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study.
Authors: Chen F. , Park S.L. , Wilkens L.R. , Wan P. , Hart S.N. , Hu C. , Yadav S.S. , Couch F.J. , Conti D.V. , de Smith A.J. , et al. .
Source: Cancer Research, 2022-07-14 00:00:00.0; , .
EPub date: 2022-07-14 00:00:00.0.
PMID: 35834270
Related Citations

Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology directed repair (HDR) functional assay.
Authors: Hu C. , Susswein L.R. , Roberts M.E. , Yang H. , Marshall M.L. , Hiraki S. , Berkofsky-Fessler W. , Gupta S. , Shen W. , Dunn C.A. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2022-06-23 00:00:00.0; , .
EPub date: 2022-06-23 00:00:00.0.
PMID: 35736817
Related Citations

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance.
Authors: Iversen E.S. , Lipton G. , Hart S.N. , Lee K.Y. , Hu C. , Polley E.C. , Pesaran T. , Yussuf A. , LaDuca H. , Chao E. , et al. .
Source: Npj Genomic Medicine, 2022-06-03 00:00:00.0; 7(1), p. 35.
EPub date: 2022-06-03 00:00:00.0.
PMID: 35665744
Related Citations

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities.
Authors: Cosgrove N. , Varešlija D. , Keelan S. , Elangovan A. , Atkinson J.M. , Cocchiglia S. , Bane F.T. , Singh V. , Furney S. , Hu C. , et al. .
Source: Nature Communications, 2022-01-26 00:00:00.0; 13(1), p. 514.
EPub date: 2022-01-26 00:00:00.0.
PMID: 35082299
Related Citations

Rare germline copy number variants (CNVs) and breast cancer risk.
Authors: Dennis J. , Tyrer J.P. , Walker L.C. , Michailidou K. , Dorling L. , Bolla M.K. , Wang Q. , Ahearn T.U. , Andrulis I.L. , Anton-Culver H. , et al. .
Source: Communications Biology, 2022-01-18 00:00:00.0; 5(1), p. 65.
EPub date: 2022-01-18 00:00:00.0.
PMID: 35042965
Related Citations

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Authors: Li H. , Engel C. , de la Hoya M. , Peterlongo P. , Yannoukakos D. , Livraghi L. , Radice P. , Thomassen M. , Hansen T.V.O. , Gerdes A.M. , et al. .
Source: Genetics In Medicine : Official Journal Of The American College Of Medical Genetics, 2022 01; 24(1), p. 119-129.
EPub date: 2021-11-30 00:00:00.0.
PMID: 34906479
Related Citations

Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.
Authors: Yadav S. , Hu C. , Nathanson K.L. , Weitzel J.N. , Goldgar D.E. , Kraft P. , Gnanaolivu R.D. , Na J. , Huang H. , Boddicker N.J. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2021-12-10 00:00:00.0; 39(35), p. 3918-3926.
EPub date: 2021-10-21 00:00:00.0.
PMID: 34672684
Related Citations

Risk of Late-Onset Breast Cancer in Genetically Predisposed Women.
Authors: Boddicker N.J. , Hu C. , Weitzel J.N. , Kraft P. , Nathanson K.L. , Goldgar D.E. , Na J. , Huang H. , Gnanaolivu R.D. , Larson N. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2021-11-01 00:00:00.0; 39(31), p. 3430-3440.
EPub date: 2021-07-22 00:00:00.0.
PMID: 34292776
Related Citations

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
Authors: Escala-Garcia M. , Canisius S. , Keeman R. , Beesley J. , Anton-Culver H. , Arndt V. , Augustinsson A. , Becher H. , Beckmann M.W. , Behrens S. , et al. .
Source: Scientific Reports, 2021-10-05 00:00:00.0; 11(1), p. 19787.
EPub date: 2021-10-05 00:00:00.0.
PMID: 34611289
Related Citations

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer.
Authors: Yadav S. , LaDuca H. , Polley E.C. , Hu C. , Niguidula N. , Shimelis H. , Lilyquist J. , Na J. , Lee K.Y. , Gutierrez S. , et al. .
Source: Journal Of The National Cancer Institute, 2021-10-01 00:00:00.0; 113(10), p. 1429-1433.
PMID: 33146377
Related Citations

Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States.
Authors: Domchek S.M. , Yao S. , Chen F. , Hu C. , Hart S.N. , Goldgar D.E. , Nathanson K.L. , Ambrosone C.B. , Haiman C.A. , Couch F.J. , et al. .
Source: Jama Oncology, 2021-07-01 00:00:00.0; 7(7), p. 1045-1050.
PMID: 34042955
Related Citations

Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score.
Authors: Gao C. , Polley E.C. , Hart S.N. , Huang H. , Hu C. , Gnanaolivu R. , Lilyquist J. , Boddicker N.J. , Na J. , Ambrosone C.B. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2021-06-08 00:00:00.0; , p. JCO2001992.
EPub date: 2021-06-08 00:00:00.0.
PMID: 34101481
Related Citations

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis.
Authors: Fasching P.A. , Yadav S. , Hu C. , Wunderle M. , Häberle L. , Hart S.N. , Rübner M. , Polley E.C. , Lee K.Y. , Gnanaolivu R.D. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2021-05-20 00:00:00.0; 39(15), p. 1619-1630.
EPub date: 2021-03-29 00:00:00.0.
PMID: 33780288
Related Citations

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance.
Authors: Richardson M.E. , Hu C. , Lee K.Y. , LaDuca H. , Fulk K. , Durda K.M. , Deckman A.M. , Goldgar D.E. , Monteiro A.N.A. , Gnanaolivu R. , et al. .
Source: American Journal Of Human Genetics, 2021-03-04 00:00:00.0; 108(3), p. 458-468.
EPub date: 2021-02-19 00:00:00.0.
PMID: 33609447
Related Citations

A Population-Based Study of Genes Previously Implicated in Breast Cancer.
Authors: Hu C. , Hart S.N. , Gnanaolivu R. , Huang H. , Lee K.Y. , Na J. , Gao C. , Lilyquist J. , Yadav S. , Boddicker N.J. , et al. .
Source: The New England Journal Of Medicine, 2021-01-20 00:00:00.0; , .
EPub date: 2021-01-20 00:00:00.0.
PMID: 33471974
Related Citations

Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers.
Authors: Kotsopoulos J. , Lubinski J. , Lynch H.T. , Tung N. , Armel S. , Senter L. , Singer C.F. , Fruscio R. , Couch F. , Weitzel J.N. , et al. .
Source: Breast Cancer Research And Treatment, 2019 Jun; 175(2), p. 443-449.
EPub date: 2019-02-12 00:00:00.0.
PMID: 30756284
Related Citations